Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: a systematic review and meta-analysis.

Elliott J, Kelly SE, Bai Z, Skidmore B, Boucher M, So D, Wells GA

Open source

DOI
10.9778/cmajo.20210119
Published
2023 Jan-Feb
Container
CMAJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.9778/cmajo.20210119,
  title = {Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: a systematic review and meta-analysis.},
  author = {Elliott J and Kelly SE and Bai Z and Skidmore B and Boucher M and So D and Wells GA},
  year = {2023},
  journal = {CMAJ open},
  doi = {10.9778/cmajo.20210119},
  url = {https://doi.org/10.9778/cmajo.20210119}
}

RIS

TY  - JOUR
TI  - Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: a systematic review and meta-analysis.
AU  - Elliott J
AU  - Kelly SE
AU  - Bai Z
AU  - Skidmore B
AU  - Boucher M
AU  - So D
AU  - Wells GA
PY  - 2023
JO  - CMAJ open
DO  - 10.9778/cmajo.20210119
UR  - https://doi.org/10.9778/cmajo.20210119
ER  - 

APA

J, E., SE, K., Z, B., B, S., M, B., D, S., & GA, W. (2023). Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: a systematic review and meta-analysis.. CMAJ open. https://doi.org/10.9778/cmajo.20210119

Source records